Lakeland, FL

Central Florida Eye Associates

Ocular Hypertension

Open-Angle Glaucoma

Glaucoma

Keratoconjunctivitis

Dry Eye Syndromes

Eye Diseases

Keratoconjunctivitis Sicca

dorzolamide

BL1107

H-1337

PG324

KPI-121

timolol maleate

Timolol

latanoprost

Alcon

Bausch + Lomb

D. Western Therapeutics Institute

Kala Pharmaceuticals

Pharmaceutical Research Network

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Central Florida Eye Associates | Lakeland, FL

Site insights

Work at this site?

Active trials

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Trial sponsors